A detailed history of Envestnet Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Envestnet Asset Management Inc holds 3,517,793 shares of AZN stock, worth $236 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,517,793
Previous 3,417,933 2.92%
Holding current value
$236 Million
Previous $267 Million 2.83%
% of portfolio
0.09%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.67 - $87.62 $7.66 Million - $8.75 Million
99,860 Added 2.92%
3,517,793 $274 Million
Q2 2024

Aug 08, 2024

BUY
$66.81 - $80.83 $32.6 Million - $39.5 Million
488,644 Added 16.68%
3,417,933 $267 Million
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $12.4 Million - $14.1 Million
203,109 Added 7.45%
2,929,289 $198 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $8.23 Million - $9.21 Million
132,970 Added 5.13%
2,726,180 $184 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $53.3 Million - $58.9 Million
821,653 Added 46.38%
2,593,210 $176 Million
Q2 2023

Aug 04, 2023

SELL
$69.91 - $75.81 $266 Million - $288 Million
-3,801,409 Reduced 68.21%
1,771,557 $127 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $257 Million - $292 Million
4,077,583 Added 272.68%
5,572,966 $387 Million
Q4 2022

Feb 07, 2023

BUY
$54.21 - $70.44 $1.03 Million - $1.34 Million
18,994 Added 1.29%
1,495,383 $101 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $24.2 Million - $62 Million
456,950 Added 44.82%
1,476,389 $81 Million
Q2 2022

Aug 03, 2022

BUY
$59.26 - $71.14 $4.1 Million - $4.93 Million
69,258 Added 7.29%
1,019,439 $67.4 Million
Q1 2022

May 04, 2022

BUY
$55.72 - $67.12 $5.12 Million - $6.16 Million
91,828 Added 10.7%
950,181 $63 Million
Q4 2021

Feb 04, 2022

BUY
$54.02 - $63.83 $5.84 Million - $6.9 Million
108,105 Added 14.41%
858,353 $50 Million
Q3 2021

Oct 07, 2021

BUY
$55.56 - $60.79 $9.39 Million - $10.3 Million
169,020 Added 29.08%
750,248 $45.1 Million
Q2 2021

Aug 04, 2021

BUY
$48.42 - $60.18 $4.67 Million - $5.81 Million
96,507 Added 19.91%
581,228 $34.8 Million
Q1 2021

May 04, 2021

BUY
$47.16 - $54.44 $3.22 Million - $3.72 Million
68,264 Added 16.39%
484,721 $24.1 Million
Q4 2020

Feb 02, 2021

BUY
$48.52 - $58.02 $1.75 Million - $2.09 Million
36,019 Added 9.47%
416,457 $20.8 Million
Q3 2020

Oct 09, 2020

SELL
$53.07 - $61.1 $368,093 - $423,789
-6,936 Reduced 1.79%
380,438 $20.8 Million
Q2 2020

Jul 08, 2020

BUY
$43.1 - $55.31 $103,009 - $132,190
2,390 Added 0.62%
387,374 $20.5 Million
Q1 2020

Apr 23, 2020

SELL
$37.79 - $51.33 $2.67 Million - $3.63 Million
-70,676 Reduced 15.51%
384,984 $17.2 Million
Q4 2019

Feb 11, 2020

SELL
$42.46 - $50.46 $58,212 - $69,180
-1,371 Reduced 0.3%
455,660 $22.7 Million
Q3 2019

Oct 17, 2019

BUY
$40.12 - $45.47 $881,677 - $999,248
21,976 Added 5.05%
457,031 $20.4 Million
Q2 2019

Aug 02, 2019

BUY
$37.28 - $41.68 $1.28 Million - $1.43 Million
34,363 Added 8.58%
435,055 $18 Million
Q1 2019

May 10, 2019

SELL
$35.49 - $43.02 $7.92 Million - $9.6 Million
-223,182 Reduced 35.77%
400,692 $16.2 Million
Q4 2018

Feb 13, 2019

BUY
$36.86 - $41.49 $22.3 Million - $25.1 Million
604,651 Added 3145.46%
623,874 $23.7 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $7.4 Million - $8.46 Million
-212,961 Reduced 91.72%
19,223 $761,000
Q2 2018

Aug 10, 2018

SELL
$34.55 - $37.05 $165,770 - $177,765
-4,798 Reduced 2.02%
232,184 $8.15 Million
Q1 2018

May 09, 2018

SELL
$32.97 - $36.63 $13.5 Million - $15 Million
-409,324 Reduced 63.33%
236,982 $8.31 Million
Q4 2017

Feb 20, 2018

SELL
$32.09 - $34.78 $48,873 - $52,969
-1,523 Reduced 0.24%
646,306 $22.4 Million
Q3 2017

Nov 13, 2017

SELL
$28.96 - $34.0 $246,449 - $289,340
-8,510 Reduced 1.3%
647,829 $21.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
656,339
656,339 $22.4 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.